High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Inclusion Criteria: * Patient must be 18 years of age or older. * Patients must have either biopsy proven or radiographically suspected non-small cell lung cancer. * Patients must have disease in the chest that is felt to be surgically resectable. * ECOG performance status of 0-2. * Ability to understand and the willingness to sign an IRB-approved informed consent document Exclusion Criteria: * Patients younger than 18 years of age * Women who are pregnant or breast feeding. * Patients may not be receiving any other investigational agents for the treatment of nonsmall cell lung cancer. * Patients may not be taking the following medications: high dose vitamin A supplement (multivitamin supplements prohibited only if vitamin A content is greater than 3,500 international units), bexarotene, alitretinoin, tretinoin, adapalene, isotretinoin, acitretin, doxycycline, minocycline, or demeclocycline, * Uncontrolled intercurrent illness including, but not limited to, pancreatitis, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements. * Hypervitaminosis A - toxic effects of ingesting too much vitamin A.